Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oropharyngeoesophageal Topical Anesthesia Prototype Device Versus Intravenous (Propofol -Ketamine Sedation) for Upper Gastrointestinal Endoscopy
NCT07563062Completed
- Sponsor
- Zagazig University
- Start
- Jan 2023
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of lidocaine 10% oropharyngeal spray, propofol injection (veterinary) and ketamine (2 arms), sponsored by Zagazig University. Primary endpoint: Patient discomfort felt during endoscopy at 24 hours. Started Jan 2023; status: completed.
02
Drugs
lidocaine 10% oropharyngeal spraypropofol injection (veterinary)ketamine
Beyond the preview
Go deeper on NCT07563062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07563062.